NASOPHARYNX CANCER
Clinical trials for NASOPHARYNX CANCER explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNX CANCER trials appear
Sign up with your email to follow new studies for NASOPHARYNX CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise for Tough-to-Treat throat cancer
Disease control CompletedThis study tested a new combination of chemotherapy drugs (nab-paclitaxel, cisplatin, and fluorouracil) followed by standard chemoradiation in 60 people with advanced nasopharyngeal cancer, a type of throat cancer common in southern China. The goal was to see if the new drug comb…
Matched conditions: NASOPHARYNX CANCER
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated May 26, 2026 11:46 UTC
-
New drug combo shows promise for tough head and neck cancers
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and cetuximab, in 78 adults with advanced head and neck cancer that had spread or come back. The goal was to see if the combo could shrink tumors or slow the disease. Patients were grouped based on whether they had tried…
Matched conditions: NASOPHARYNX CANCER
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated May 26, 2026 11:34 UTC